openPR Logo
Press release

Rising Prevalence of Glioblastoma Multiforme Triggers Development of Novel Therapeutics

07-13-2018 09:10 AM CET | Health & Medicine

Press release from: Market Research Hub

Rising Prevalence of Glioblastoma Multiforme Triggers

Higher prevalence of glioblastoma multiforme, a rapidly spreading brain tumor, has been witnessed across the globe, especially in developed countries. For instance, according to WHO, about 10,000 cases of glioblastoma multiforme are diagnose on an annual basis in United States alone Moreover, the National Cancer Institute revealed that GBM or glioblastoma multiforme has an incidence rate of two to three individuals per 100,000 adults annually at global level and glioblastoma multiforme accounts for around 17 percent of the brain tumors, including both metastatic and primary brain cancers. That said, pharmaceutical companies are striving to develop advanced therapeutics to facilitate effective treatment of this type of cancer. A new research report showcasing pipeline review for H1 2018 for glioblastoma multiforme titled “Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018” has been added to the research repository of Market Research Hub (MRH).

Request here for Free Sample Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1843573

Typically occurring between ages of 45 and 70, likelihood of development of glioblastoma multiforme in aged people is higher as compared to adults. This has caused a sense of concern among nations with higher aged population, such as Japan, which led to the development of novel therapeutics to treat the disease.

With an increased focus on research and development, various companies are trying different possibilities for treatment in the gene therapy and molecular biotechnology space in order to find innovative possibilities for GBM treatment. The glioblastoma multiforme pipeline review for H1 2018 includes analysis associated with development of therapeutics, their assessment along with various drugs used in treatment of glioblastoma multiforme.

Glioblastoma Multiforme Pipeline Review- H1, 2018: Report Overview

The report on glioblastoma multiforme pipeline review for H1, 2018 begins with a brief introduction on the overall glioblastoma multiforme scenario. The introduction section of the report covers a general overview of the market, followed by intelligence on therapeutics development, therapeutics assessment, various companies involved in the development of therapeutics for glioblastoma multiforme, drug profiles used in glioblastoma multiforme treatment, dormant and discontinued projects and product development milestones.

The research report on glioblastoma multiforme pipeline review, H1 2018, offers a complete intelligence assessment on therapeutics under development along with stages of development, target drug, MoA (Mechanism of Action), RoA (Route of Administration) and molecule type. The report also covers vivid pharmacological action of therapeutics, complete research of this pharmacological action and history of development along with latest press releases and news.

Browse Full Report with Full Table of Content@ https://www.marketresearchhub.com/report/glioblastoma-multiforme-gbm-pipeline-review-h1-2018-report.html

Glioblastoma Multiforme Pipeline Review- H1, 2018: Companies Involved in Development

The report on glioblastoma multiforme pipeline review, H1, 2018, includes analysis on various companies involved in development of glioblastoma multiforme therapeutics. The section reveals therapeutics under development by universities, companies and institutes, development of molecules by companies in phase 3, phase 2, phase 1, phase 0, CTA/IND Filed, discovery, preclinical and unknown stages. Likewise, all these aspects are taken into consideration with respect to university trials for glioblastoma multiforme pipeline development.

The report on glioblastoma multiforme pipeline review, H1 2018, supports the reader in tracking and identifying evolving players in the glioblastoma multiforme market that facilitates in effective decision making in order to create efficient counter strategies to gain competitive edge. This report is fabricated using registries of clinical trials, SEC filings, conferences, university and company websites, investor presentations and press releases.

Glioblastoma Multiforme Pipeline Review- H1, 2018: Reasons to Invest in This Study

This report covers in-depth intelligence on various clinical trials revealing pipeline analysis for glioblastoma multiforme during H1 of 2018. In addition, the report on glioblastoma multiforme pipeline analysis, H1 2018, includes analysis on dormant projects or discontinued projects that can be used by upcoming companies as a new opportunity in this space.  

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like pharmaceutical industry research reports and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

ContactUs                                                                                                     

90 State Street,
Albany, NY 12207,
United States

Toll Free: 800-998-4852 (US-Canada)
Email: press@marketresearchhub.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Prevalence of Glioblastoma Multiforme Triggers Development of Novel Therapeutics here

News-ID: 1124161 • Views:

More Releases from Market Research Hub

Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Acrylate Polymers Market Professional Survey Report 2019”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Acrylate Polymers Market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, Leading Players : DEWALT, Shark,Benchmark Abrasives,Bosch,Hot Max Up to 2025
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, …
Market Research Hub (MRH) has recently uploaded a new study titled “Global Abrasive Wheels & Discs Market Professional Survey Report 2019” to its broad online storehouse. The global Abrasive Wheels & Discs Market conveniently covers prime factors motivating development and steering industry trends and demand scenarios. Readers can easily quantify market opportunities with the availability of information such as market sizing and market forecasting, thereby being able to analyze the
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, Stiplastics S.A.S, Argo S.A, Gramb GmbH Kunststoffverarbeitung, Origin Pharma Packaging, Eastman Chemical Company, Yuyao Liantong Plastic & Mould Co., Ltd
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Oral Dosing Cups Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Oral Dosing Cups market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstock, MingYue, Conant, Wanxin, CHEMI, Nikon
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstoc …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Opthalmic Lenses Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Opthalmic Lenses market*. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the

All 5 Releases


More Releases for Glioblastoma

Understanding Impact of COVID-19 on Glioblastoma Multiforme (GBM) Market
Glioblastoma Multiforme (GBM), also known as glioblastoma, is a form of brain cancer. It is a rapidly-growing glioma that develops from star-shaped glial cells, such as oligodendrocytes and astrocytes that support the nerve cells in the brain. GBM is also called as grade IV astrocytoma and is among the most invasive forms of glial tumors. It is a fast-growing and aggressive form of tumor in the central nervous system (CNS)
2019 - 2025 Glioblastoma Multiforme Treatment Market | GBM Market
Global Glioblastoma Multiforme Treatment Market, Its Market Trends And Analysis Glioblastoma multiforme is the high-grade glioma and potent malignant brain tumor that affects glial cells. Glioblastoma multiforme contains the complexly differentiated neoplastic astrocytes which are the subtype of central nervous system. Glioblastoma multiforme is different from the anaplastic astrocytoma due to the presence of hyperplastic blood vessels and necrotic tissue. Request Sample Report: https://precisionbusinessinsights.com/request-sample?product_id=16248 The global glioblastoma multiforme treatment market is
Glioblastoma Treatment Drugs Market : Drivers, Restraint & Future Growth
Brain tumors is one of the leading cause of cancer which is common among children and teenagers. Glioblastoma (GBM) is most common grade four tumor, is malignant and contains dead tumor cells. It is also called as Glioblastoma multiforme, it has variants of giant cell Glioblastoma and gliosarcoma found in cerebral hemisphere of brain. The exact cause of this tumor is not known but is also found in spinal cord
Glioblastoma Multiforme Treatment Market : Global Glioblastoma Multiforme Treatm …
Glioblastoma Multiforme Treatment Market Precision Business Insights (PBI) in its report titled “Global Glioblastoma Multiforme Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Glioblastoma multiforme is the high-grade glioma and
Glioblastoma Multiforme Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2017, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape. Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor. GBMs arise from glial cells, which are cells that form the tissue that surrounds and protects other nerve cells found within the brain and spinal cord. GBMs are mainly composed of star-shaped glial
Glioblastoma Multiforme Treatment (GBM) Industry Analysis by Segments
Glioblastoma multiforme (GBM) is a high-grade gliomas and the most malignant astrocytic tumor, composed of complexly differentiated neoplastic astrocytes, a subtype of central nervous system (CNS). Glioblastoma is clinically classified as grade IV astrocytoma and differs from anaplastic astrocytoma (grade III) due to the presence of necrotic tissue and hyperplastic blood vessels. The diagnosis of GBM is carried out with imaging modules such as computed tomography (CT), magnetic resonance imaging